Kamimura_2017_BMC.Cancer_17_322

Reference

Title : Transhepatic arterial infusion chemotherapy using a combination of miriplatin and CDDP powder versus miriplatin alone in the treatment of hepatocellular carcinoma: a randomized controlled trial - Kamimura_2017_BMC.Cancer_17_322
Author(s) : Kamimura K , Suda T , Yokoo T , Kamimura H , Kanefuji T , Tsuchiya A , Takamura M , Kawai H , Waguri N , Yamagiwa S , Terai S
Ref : BMC Cancer , 17 :322 , 2017
Abstract : Kamimura_2017_BMC.Cancer_17_322
ESTHER : Kamimura_2017_BMC.Cancer_17_322
PubMedSearch : Kamimura_2017_BMC.Cancer_17_322
PubMedID: 28490356

Related information

Citations formats

Kamimura K, Suda T, Yokoo T, Kamimura H, Kanefuji T, Tsuchiya A, Takamura M, Kawai H, Waguri N, Yamagiwa S, Terai S (2017)
Transhepatic arterial infusion chemotherapy using a combination of miriplatin and CDDP powder versus miriplatin alone in the treatment of hepatocellular carcinoma: a randomized controlled trial
BMC Cancer 17 :322

Kamimura K, Suda T, Yokoo T, Kamimura H, Kanefuji T, Tsuchiya A, Takamura M, Kawai H, Waguri N, Yamagiwa S, Terai S (2017)
BMC Cancer 17 :322